Team cannabis 4 epilepsy
e are participating in the Walk to End Epilepsy on Saturday, February 2nd, 2019 at the Rose Bowl Stadium in Pasadena to join in the fight to END EPILEPSY.
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity
A large proportion of patients with multiple sclerosis (MS) have spasticity, which has a marked impact on their quality of life. Anecdotal evidence suggests a beneficial effect of cannabis on spasticity as well as pain. Recently, randomized, double-blind, placebo-controlled studies have confirmed the clinical efficacy of cannabinoids for the treatment of spasticity in patients with MS.
